Korean Red Ginseng extract (KRG, Panax ginseng Meyer) and its constituents have been used for the treatment of diabetes. However, it remains unclear whether KRG can enhance the glucose-lowering action of rosiglitazone (ROSI), a peroxisome proliferator-activated receptor gamma synthetic activator, in diet-induced obese mice.